Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07500012 · ClinicalTrials.gov registry record · NA
taVNS for Breast Cancer Pain and Symptom Management
A NA study, sponsored by Florida State University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07500012 is a NA study that is actively recruiting participants, run by Florida State University. The registered enrollment target is 40 participants.
The verdict
NCT07500012, a NA study, is actively recruiting participants, sponsored by Florida State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors. 2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-gut axis (BGA) in breast cancer survivors.
Interventions
- DEVICE Sham taVNS
- DEVICE Active taVNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2028-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07500012
The ClinicalTrials.gov registry entry for NCT07500012 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham taVNS is the first listed.
NCT07500012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07500012 about?
NCT07500012 is a clinical study titled "taVNS for Breast Cancer Pain and Symptom Management". 1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors. 2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-gut axis (BGA) in bre...
What is the current status of trial NCT07500012?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-24. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07500012?
The interventions under investigation include: Sham taVNS (DEVICE), Active taVNS (DEVICE).
Who is sponsoring clinical trial NCT07500012?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.